“Simply replacing clinicians with an algorithm is not the solution but making patients active partners in their treatment process is. Smartphones can be used to achieve that goal,” according to Prof. Inez Myin-Germeys (Center for Contextual Psychiatry, Belgium). She explained the Experience Sampling Method, where people are asked many types of questions about their daily life. Smartphones can help to give this a clinical meaning and bring it into the clinic.
Prof. Myin-Germeys and colleagues developed an approach called Digital Mobile Mental Health, which can support personalised medicine. “Individualised data helps to feed the discussion between patient and physician. Providing patients with feedback on their normal daily life patterns is very helpful for self-management and recovery. It is also useful for the clinician to define personalised targets for treatment.”
Digital Mobile Mental Health puts the individual at the centre of their treatment, as they collect the data themselves, making them active partners. Prof. Myin-Germeys concluded that smartphone interventions have a large potential as these interventions can have an added value in the clinic. “Nevertheless, we need to overcome issues such as privacy, data safety, and technology sustainability, amongst others, so that it can find its way into daily practice. Only then can smartphone intervention help in providing truly person-centred care in psychiatry.”
- Myin-Germeys I. Digital self-monitoring: a step towards personalised medicine in psychiatry. S21.03. ECNP Congress 2020.
Posted on
Previous Article
« Baby’s heart rate shows stress if their mother is depressed or anxious Next Article
The PRISM project: focusing on biological parameters across neuropsychiatric disorders »
« Baby’s heart rate shows stress if their mother is depressed or anxious Next Article
The PRISM project: focusing on biological parameters across neuropsychiatric disorders »
Table of Contents: ECNP 2020
Featured articles
Psychosis and Schizophrenia
Prognostic tools in the management of clinical high risk for psychosis
Reduced auditory cortex activation during speech perception in patients with schizophrenia
Dementia
Predicting MCI and dementia by assessing worrying about memory
Genomics of vascular dementia and stroke
Bipolar Disorders
Social media and bipolar disorder: a risky combination
How to prevent the onset and first relapse of bipolar disorders?
Seasonal pattern and bipolar disorder
OCD and Depression
Personalised medicine in depression: a realistic way forward?
Heart rate could be a potential biomarker for depression
Listening to Mozart has a beneficial effect on epilepsy
Mental Health
Mental health during the COVID-19 pandemic
Microdosing psychedelics offers perspective but needs further evaluation
The PRISM project: focusing on biological parameters across neuropsychiatric disorders
Smartphone can support personalised medicine in psychiatry
Baby’s heart rate shows stress if their mother is depressed or anxious
Autism and ADHD
Movement computing promising in analysing motor impairment in children with autism spectrum disorder
Screening with ADHD Self-Report accurate in girls
No altered fractional anisotropy in ADHD
Role of the Microbiome
Micronutrient supplementation as treatment for psychiatric symptoms
Substance Abuse
Altered gene expression of endogenous opioid system after alcohol exposure in adolescent rodents
Subgroups in alcohol use disorder based on externalising symptoms
New drugs for alcohol use disorder to focus on combination therapy
Related Articles
October 13, 2020
Lyme neuroborreliosis does not seem to boost psychiatric risk
November 28, 2022
Letter from the Editor
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com